000 01163 a2200349 4500
005 20250515204656.0
264 0 _c20100610
008 201006s 0 0 eng d
022 _a1167-1122
024 7 _a10.1684/ejd.2010.0847
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHegarty, Anne M
245 0 0 _aDapsone efficacy and adverse events in the management of mucous membrane pemphigoid.
_h[electronic resource]
260 _bEuropean journal of dermatology : EJD
_c
300 _a223-4 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aDapsone
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeprostatic Agents
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPemphigoid, Benign Mucous Membrane
_xdrug therapy
700 1 _aOrmond, Martyn
700 1 _aSweeney, Maureen
700 1 _aHodgson, Tim
773 0 _tEuropean journal of dermatology : EJD
_gvol. 20
_gno. 2
_gp. 223-4
856 4 0 _uhttps://doi.org/10.1684/ejd.2010.0847
_zAvailable from publisher's website
999 _c19495808
_d19495808